ESMO Breast Cancer 2026 in Berlin, Germany

ESMO Breast Cancer 2026 is a specialized international congress dedicated to breast cancer, covering everything from molecular diagnostics and biomarkers to treatment strategies and patient management at every stage.

The format combines onsite and online participation, making it convenient for teams who do not want to step away from clinical work but still need access to the latest data.

Video about ESMO Breast Cancer: experience the format before you travel

ESMO offers video content from the ESMO Breast series, including playlists where experts explain why participation matters and which topics will be in focus. It is a practical way to get into the mindset of the congress in advance and set your personal priorities.

Who will benefit from ESMO Breast Cancer

This is a congress for professionals who make decisions and work in multidisciplinary teams. Practical value is key here: data you can already discuss at your tumor board next week.

• medical oncologists and clinical oncologists managing early and metastatic disease;
• chemotherapists, radiation oncologists, breast surgeons, and reconstruction specialists;
• pathologists and molecular diagnostics experts responsible for biomarker testing;
• researchers and clinical trial coordinators;
• nurses and patient navigators involved in supportive care;
• pharmaceutical and medtech companies active in breast oncology and related fields.

History of ESMO Breast Cancer and key milestones

The congress has long outgrown the format of a “niche meeting”. It has become an annual gathering point for the community, where innovations, new drugs and treatment strategies are discussed, alongside quality of life and access to therapy.

One marker of its maturity is a stable international audience and a hybrid format. For example, ESMO Breast Cancer 2024 took place in Berlin as a hybrid meeting (onsite and online), while ESMO Breast Cancer 2025 was held in Munich and was also accessible via a virtual platform.

The 2025 edition showed clear growth and market interest. According to ESMO, the Munich event welcomed more than 3,600 participants, underlining that the congress is seen as a practical must-attend for breast oncology.

Why ESMO Breast Cancer 2026 stands out among breast oncology events

The strength of the congress lies in its focus and content density. There is no dilution across dozens of disease areas: attention stays on one field, allowing discussions to go deeper and become more concrete.

• Specialization in breast cancer: from early detection to treatment and long-term follow-up.
• Global community and an international perspective: Berlin brings clinicians and researchers from many countries together in one place.
• Onsite + online: you can attend in person or join remotely via the virtual platform.
• Science meets practice: the exhibition and industry formats help quickly translate data into real-world diagnostic and therapeutic decisions.
• Clear industry framework: ESMO offers defined rules and packages for companies, including sponsorship, exhibition participation, symposia, and preparatory materials.

ESMO Breast Cancer 2026 in Berlin: venue and logistics

The venue for ESMO Breast Cancer 2026 is hub27 – Messe Berlin. This modern space is designed for large-scale medical events and makes it easy to combine scientific sessions with the industry exhibition.

Maritim Hotel Berlin remains an excellent base: it is chosen for its service level, comfort for business travel, and the opportunity to hold team meetings in a calm setting before and after intense congress days.

6 well-known companies at ESMO Breast Cancer: who to visit at the booths

The exhibitor mix may vary from year to year, but based on ESMO materials from previous editions and the industry exhibition, several strong and recognizable brands consistently stand out. These are companies shaping therapy and supporting clinical practice.

• AstraZeneca

  The company is highly visible in breast oncology thanks to an active clinical program and a portfolio frequently discussed in scientific sessions and professional circles. Visitors come to their booth to talk about data, patient selection criteria, and real-world implementation scenarios.

• Daiichi Sankyo

  One of the most talked-about players in recent years, especially at the intersection of innovation and real-world practice. Their booth usually offers valuable insights into research programs and professional materials for physicians.

• Pfizer Oncology

  A classic heavyweight in oncology, relevant for those tracking new data and evolving treatment standards. It is a good place to compare how strategies change and which questions remain open.

• MSD

  The company is a regular presence at major ESMO medical events and focuses on modern therapies, combination approaches, and practical aspects of patient management.

• Menarini Stemline

  An exhibitor of interest to audiences focused on new therapeutic options and the evolution of clinical approaches. Their booth is a good place to ask about the company’s focus in breast oncology and their view on how practice is changing.

• Eli Lilly and Company

  Listed among the sponsors of ESMO Breast Cancer 2026. For attendees, this signals a strong industry presence and the opportunity to discuss research and educational initiatives in a live, in-person format.

Categories of solutions and services at ESMO Breast Cancer 2026

At this congress, “exhibits” are not displays for the sake of display, but solutions that actively support clinical practice and research. Based on ESMO materials from previous editions and industry participation, several key categories can be identified.

• Drug therapy and research:
  • oncology drugs and clinical research programs;
  • educational and scientific initiatives for HCPs.
• Diagnostics and biomarkers:
  • molecular tests and patient stratification solutions;
  • companion diagnostics and laboratory services.
• Digital services and clinical support:
  • platforms for education, medical information, and HCP engagement;
  • tools supporting clinical decision-making and patient pathways.
• Supportive care and quality of life:
  • management of complications and long-term follow-up approaches;
  • patient-centered services and materials.

Recommendations for ESMO Breast Cancer attendees: how to get the most out of 3 days

This congress is best approached with a clear plan. That way, Berlin will be remembered not for exhaustion, but for the feeling that your practice has truly been updated.

• Before the trip:
  • prepare a list of topics and questions for your team and tumor board;
  • block time for key sessions and the exhibition to avoid rushing between halls;
  • if attending online, check access to the virtual platform and agenda in advance.
• Onsite:
  • arrive early for morning sessions: fewer queues and easier seating;
  • after presentations, visit booths of companies whose data were discussed and ask specific questions;
  • schedule short meetings: 15 minutes often deliver more value than long follow-up emails.
• After:
  • create a short internal summary: 10 key takeaways, 3 practice changes, 3 research ideas;
  • capture contacts and agreements while they are still fresh.

How to participate in ESMO Breast Cancer 2026 as an exhibitor

For companies, participation is built around the official industry program: exhibition, sponsorship, satellite symposia, and other formats described by ESMO in dedicated sections for industry partners.

• What typically needs preparation:
  • selection of participation format and package, booking space and options;
  • compliance materials and preparatory documents for HCP engagement;
  • goals and KPIs: leads, meetings, educational activities, audience reach;
  • demos and content: clear 3–5 minute conversation scenarios, relevant for physicians and department heads.

If you want to present yourself at ESMO Breast Cancer 2026 in a confident and modern way, you can choose custom exhibition stand construction or exhibition stand rental from ESBAU – a professional exhibition stand builder in Europe. This approach helps create a clean, medically appropriate stand that remains visible, with the right areas for meetings and private discussions.